Insulet appoints Jay Mazelsky to board of directors
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Insulet Corporation (PODD)
Track today's live Insulet (PODD) share price, performance and key data on this page with our current NASDAQ:PODD stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Insulet share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PODD share price, head to our technical summary section, which provides analysis on Insulet share price buy/sell indicators using real-time data (or discuss the Insulet (PODD) stock price today with other investors in the Insulet NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PODD share price (ISIN: US45784P1012) to enhance your trading decisions with our free investment tools and resources.
What Is the Insulet Corporation Share Price Today?
The Insulet share price today is 148.88.
What Is the Stock Symbol for Insulet Corporation
The stock symbol (or 'ticker') for Insulet Corporation is "PODD."
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PODD share price (ISIN: US45784P1012) to enhance your trading decisions with our free investment tools and resources.
What Is the Insulet Corporation Share Price Today?
The Insulet share price today is 148.88.
What Is the Stock Symbol for Insulet Corporation
The stock symbol (or 'ticker') for Insulet Corporation is "PODD."
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in USD
153.63
+4.75(+3.19%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
148.02
154.14
52 wk Range
138.79
354.88
PODD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
148.02154.14
52 wk Range
138.79354.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PODD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
240.25
Upside
+56.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
22 Buy
3 Hold
0 Sell
Ratings:
25 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 240.25
(+56.38% Upside)
Insulet Corporation SWOT Analysis
Patch Pump Pionee | Insulet leads the diabetes management market with innovative patch pump technology, boasting impressive financial health and a "GREAT" rating from InvestingPro |
Growth Trajectory | Explore Insulet's robust Q1 2025 performance, revised revenue guidance, and strategic expansion into Type 2 diabetes market, driving substantial growth |
Leadership Transition | New CEO Ashley McEvoy's appointment signals potential for accelerated growth and market expansion, despite initial investor uncertainty |
Market Valuation | Delve into Insulet's high valuation multiples, with analyst price targets ranging from $266 to $365, reflecting strong growth prospects in medical technology |
Insulet Corporation Earnings Call Summary for Q1/2026
- Q1 2026 EPS of $1.42 beat estimates by 18.3%; revenue reached $761.7M, exceeding forecasts by 4.4% with 34% YoY growth driven by Omnipod sales.
- GAAP gross margin hit 69.5% while adjusted operating margin improved 110 basis points to 17.5%, reflecting strong operational execution.
- Stock declined 0.3% premarket to $167.02 despite earnings beat; shares down 48% over six months, trading near 52-week low of $158.35.
- Company guided Q2-Q4 2026 EPS between $1.48-$2.02 and revenue of $788M-$935M; announced Omnipod 5 integration with FreeStyle Libre 3 Plus.
- Management cited innovation focus and market expansion plans; acknowledged margin pressure risks from exit costs and supply chain disruptions.
Last Updated: 06/05/2026, 14:34
Read Full TranscriptEarnings
Latest Release
06/05/2026
EPS / Forecast
1.42 / 1.20
Revenue / Forecast
761.7M / 729.9M
Compare PODD to Peers and Sector
Metrics to compare | PODD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPODDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.4x | −6.3x | −0.4x | |
PEG Ratio | −1.50 | 0.01 | 0.00 | |
Price/Book | 8.0x | 3.5x | 2.6x | |
Price / LTM Sales | 3.6x | 3.2x | 3.0x | |
Upside (Analyst Target) | 66.2% | 36.4% | 55.7% | |
Fair Value Upside | Unlock | 12.8% | 8.1% | Unlock |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Insulet (NASDAQ: PODD) Share Price Today?
The Insulet stock price today is 153.63 USD.
What Stock Exchange Does Insulet (PODD) Trade On?
Insulet is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Insulet?
The stock symbol (also called a 'ticker') for Insulet is "PODD."
What Is the Current Insulet Market Capitalisation?
As of today, Insulet (NASDAQ: PODD) market cap is 10.47B USD.
What Is Insulet's (PODD) Earnings Per Share (TTM)?
The Insulet EPS is currently 4.29 (Trailing Twelve Months).
When Is the Next Insulet Earnings Date?
Insulet's next earnings report will be released on 06/08/2026.
Is PODD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Insulet moving averages and other technical indicators, the daily buy/sell signal for PODD stock is Neutral.
How Many Times Has Insulet Stock Split?
Insulet has split 0 times. (See the PODD stock split history page for full effective split date and price information.)
How Many Employees Does Insulet Have?
Insulet has 5400 employees, based on their latest Companies House report.
What is the current trading status of Insulet (NASDAQ: PODD)?
As of 25/06/2026, Insulet (PODD) is trading at a share price of 153.63 USD, with a previous close of 148.88 USD. The stock has fluctuated within a day range of 148.02 USD to 154.14 USD, while its 52-week range spans from 138.79 USD to 354.88 USD.
What Is Insulet (PODD) Price Target According to Analysts?
The average 12-month price target for Insulet is 240.25 USD, with a high estimate of 360 USD and a low estimate of 165 USD. 22 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +56.38% Upside potential.
What Is the PODD Premarket Price?
PODD's last pre-market stock price is 148.00 USD. The pre-market share volume is 160.00, and the stock has decreased by -0.88, or -0.59%.
What Is the PODD After Hours Price?
PODD's last after hours stock price is 149.51 USD, the stock has decreased by 0.63, or 0.42%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.